Related Experiment Video

Updated: Jun 28, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

An overview of viral and viral-like agents in cell culture systems

J C Petricciani1

  • 1International Association of Biological Standardization, P.O.Box 1925, Palm Springs, CA, 92263-1925, U.S.A., jpmdpsca@aol.com.

Cytotechnology
|November 13, 2008
PubMed

Insights

Biological product contamination, including viral agents like SV-40 in polio vaccines, has been recognized for a century. This review examines historical incidents and discusses current challenges in ensuring product safety.

Area of Science:

  • Biotechnology
  • Pharmaceutical Science
  • Public Health

Background:

  • Biological product safety is critical, with contamination posing significant risks.
  • Historical incidents highlight the long-standing challenge of ensuring product purity.
  • The identification of simian virus 40 (SV-40) in polio vaccines underscored viral contamination risks.

Purpose of the Study:

  • To review the history of contamination incidents in biological products.
  • To discuss the evolving challenges of viral and viral-like agent contamination.
  • To provide context for current issues in biological product safety.

Main Methods:

  • Historical literature review of contamination events.
  • Analysis of key contamination incidents, including viral agents.
  • Discussion of contemporary challenges in contamination control.

Main Results:

  • Contamination of biological products has been a recognized issue for nearly 100 years.
  • Viral contamination, exemplified by SV-40 in polio vaccines, emerged as a major concern in the latter half of the 20th century.
  • Ongoing vigilance and evolving strategies are necessary to address contamination risks.

Conclusions:

  • Understanding the history of contamination is crucial for preventing future incidents.
  • Continuous improvement in manufacturing and testing is essential for biological product safety.
  • Addressing viral and viral-like agent contamination remains a key focus in pharmaceutical development.

More Related Videos

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems09:28

Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems

Published on: November 4, 2014

Related Concept Videos

Introduction to Virus01:28

Introduction to Virus

Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
What are Viruses?00:50

What are Viruses?

Overview
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.